Potassium Phosphates Injection, Solution
Product Images NDC 0517-2102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Potassium Phosphates (NDC 0517-2102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ari Logo (Potassium Phosphates Anda 216274 1)

FDA Label Image

5mlvial (Potassium Phosphates Anda 216274 2)

5mlvial (Potassium Phosphates Anda 216274 2)
Label for Potassium Phosphates Injection, USP, an intravenous injection solution by American Regent, Inc. The vial contains 5 mL single-dose with 15 mmol phosphorus and 22 mEq potassium per 5 mL, corresponding to 3 mmol/mL and 4.4 mEq/mL concentrations. The product is sterile, nonpyrogenic, preservative-free, and must be diluted before intravenous use. Storage instructions are included.*
FDA Label Image

5mltray (Potassium Phosphates Anda 216274 3)

5mltray (Potassium Phosphates Anda 216274 3)
Potassium Phosphates Injection, USP label for intravenous solution, containing 15 mmol/5 mL (3 mmol/mL) Phosphorus and 22 meq/5 mL (4.4 meq/mL) Potassium. The package contains 25 single-dose 5 mL vials. Manufactured by American Regent, Inc. with a caution that the product must be diluted before use.*
FDA Label Image

15mlvial (Potassium Phosphates Anda 216274 4)

15mlvial (Potassium Phosphates Anda 216274 4)
Potassium Phosphates Injection, USP solution label for intravenous use. The vial contains 15 mL single-dose with active ingredients monobasic potassium phosphate 224 mg/mL and dibasic potassium phosphate 236 mg/mL. The label states the product is sterile, nonpyrogenic, preservative-free, and must be diluted before use. It is distributed by American Regent, Inc.*
FDA Label Image

15mltray (Potassium Phosphates Anda 216274 5)

15mltray (Potassium Phosphates Anda 216274 5)
Potassium Phosphates Injection, USP carton label for intravenous use by American Regent, Inc. The label indicates a package of 25 single-dose vials, each containing 15 mL solution. The strength is given as phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 66 mEq/15 mL (4.4 mEq/mL), with a caution that the product must be diluted before use.*
FDA Label Image

50mlvial (Potassium Phosphates Anda 216274 6)

50mlvial (Potassium Phosphates Anda 216274 6)
Potassium Phosphates Injection, USP sterile solution for intravenous use by American Regent, Inc. The label shows strengths of monobasic potassium phosphate 224 mg/mL and dibasic potassium phosphate 236 mg/mL in a 50 mL pharmacy bulk package. It includes warnings that the product is preservative free, must be diluted, and is not for direct infusion. Storage instructions and dosing information references are provided.*
FDA Label Image

50 mL Tray (Potassium Phosphates Anda 216274 7)

50 mL Tray (Potassium Phosphates Anda 216274 7)
Potassium Phosphates Injection, USP label for a pharmacy bulk package of 25 vials, each 50 mL, containing 150 mmol phosphorus and 220 mEq potassium per 50 mL. The label states it is for intravenous use only, must be diluted before administration, and is not for direct infusion. Manufactured by American Regent, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.